These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10516710)

  • 1. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan.
    Kinugawa N; Imashuku S; Hirota Y; Yamada K; Yamamoto A; Akazai A; Oda M; Miura N; Kakuta H; Sato T; Endo M; Takano T
    Bone Marrow Transplant; 1999 Oct; 24(8):935-8. PubMed ID: 10516710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group.
    Akkari V; Donadieu J; Piguet C; Bordigoni P; Michel G; Blanche S; Casanova JL; Thomas C; Vilmer E; Fischer A; Bertrand Y;
    Bone Marrow Transplant; 2003 Jun; 31(12):1097-103. PubMed ID: 12796789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation in Langerhans cell histiocytosis: case report and review of the literature.
    Kesik V; Citak C; Kismet E; Koseoglu V; Akyuz C
    Pediatr Transplant; 2009 May; 13(3):371-4. PubMed ID: 18518907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan.
    Kudo K; Ohga S; Morimoto A; Ishida Y; Suzuki N; Hasegawa D; Nagatoshi Y; Kato S; Ishii E
    Bone Marrow Transplant; 2010 May; 45(5):901-6. PubMed ID: 19767778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Steiner M; Matthes-Martin S; Attarbaschi A; Minkov M; Grois N; Unger E; Holter W; Vormoor J; Wawer A; Ouachee M; Woessmann W; Gadner H
    Bone Marrow Transplant; 2005 Aug; 36(3):215-25. PubMed ID: 15937510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical parental hematopoietic stem cell transplantation in pediatric refractory Langerhans cell histiocytosis.
    Jun Y; Quan QM; Bin W; Hua ZG; Li Z; Rui Z; Guang JC; Hao MH; Long DY; Jing Y; Xuan Z
    Pediatr Transplant; 2014 Jun; 18(4):E124-9. PubMed ID: 24641492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosis.
    Kudo K; Maeda M; Suzuki N; Kanegane H; Ohga S; Ishii E; Shioda Y; Imamura T; Imashuku S; Tsunematsu Y; Endo M; Shimada A; Koga Y; Hashii Y; Noguchi M; Inoue M; Tabuchi K; Morimoto A;
    Int J Hematol; 2020 Jan; 111(1):137-148. PubMed ID: 31758416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.
    Woessmann W; Peters C; Lenhard M; Burkhardt B; Sykora KW; Dilloo D; Kremens B; Lang P; Führer M; Kühne T; Parwaresch R; Ebell W; Reiter A
    Br J Haematol; 2006 Apr; 133(2):176-82. PubMed ID: 16611309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.
    Veys PA; Nanduri V; Baker KS; He W; Bandini G; Biondi A; Dalissier A; Davis JH; Eames GM; Egeler RM; Filipovich AH; Fischer A; Jürgens H; Krance R; Lanino E; Leung WH; Matthes S; Michel G; Orchard PJ; Pieczonka A; Ringdén O; Schlegel PG; Sirvent A; Vettenranta K; Eapen M
    Br J Haematol; 2015 Jun; 169(5):711-8. PubMed ID: 25817915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan.
    Asano T; Kogawa K; Morimoto A; Ishida Y; Suzuki N; Ohga S; Kudo K; Ohta S; Wakiguchi H; Tabuchi K; Kato S; Ishii E
    Pediatr Blood Cancer; 2012 Jul; 59(1):110-4. PubMed ID: 22038983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
    Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
    Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
    Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis.
    Cooper N; Rao K; Goulden N; Webb D; Amrolia P; Veys P
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S47-50. PubMed ID: 18978744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hungarian experience with Langerhans cell histiocytosis in childhood.
    Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G;
    Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
    Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
    Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation for refractory Langerhans' cell histiocytosis.
    Conter V; Reciputo A; Arrigo C; Bozzato N; Sala A; Aricò M
    Haematologica; 1996; 81(5):468-71. PubMed ID: 8952163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis.
    Kager L; Heise A; Minkov M; Möbius D; Kotte W; Schulte-Overberg U; Henze G; Gadner H
    Pediatr Hematol Oncol; 1999; 16(3):251-6. PubMed ID: 10326224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.